MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02171nab a22002417a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221123182210.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
150723s9999 xx 000 0 und d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
MANILA TYTANA COLLEGES LIBRARY |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cheong, Magdalin. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Folic acid fortified milk increases blood folate to concentrations associated with a very low risk of neural tube defects in Singaporean women of childbearing age / |
| Statement of responsibility, etc. |
Magdalin Cheong, Huang Ying Xiao, Vicky Tay, Crystal D. Karakochuk, Yazheng Amy Liu, Sarah Harvey, Yvonne Lamers, Lisa A. Houghton, David D Kitts, Tim J. Green |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc. |
2016 |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
txt. |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated. |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Title |
Asia Pacific Journal of Clinical Nutrition |
| Number of part/section of a work |
25 : 1 page 62-70 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Background and Objectives: Folic acid (400 g/d) taken during the periconceptional period reduces neural tube defect (NTD) risk by >75%. Achieving red cell folate (RCF) or plasma folate (PF) >905 nmol/L and >35 nmol/L, respectively, has been associated with a low risk of NTDs. We determined whether daily consumption of folic acid fortified milk increases blood folate concentrations to levels associated with a low risk of NTDs in Singaporean women of childbearing age. Methods and Study Design: In this double-blind placebo-controlled trial, 70 non-pregnant women (21-35 y) were randomly assigned to receive fortified milk (FM) powder providing 400 g folic acid per day or unfortified placebo milk (PM) powder for 12 weeks. Blood samples were collected at baseline and at 6 and 12 weeks. Results: At 12 weeks, mean (95% CI) RCF and PF concentrations were 376 (240, 512) and 39 (26, 51) nmol/L higher in the FM group compared with the PM group (p<0.001). Of the women receiving FM, 71% (n=25) and 86% (n=30) achieved a RCF and PF associated with a very low risk of NTDs, respectively. Conclusion: Folic acid fortified milk increased blood folate concentrations in women of childbearing age to levels associated with a reduced risk of an NTD-affected pregnancy. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Nutrition |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Folic acid. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Neural tube defects. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Articles |
| Source of classification or shelving scheme |
Library of Congress Classification |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| Cataloger's initials, CIN (RLIN) |
78663 |
| First Date, FD (RLIN) |
137026 |
